EGFR and non-small cell lung carcinoma: Although the functional role of AXL in NSCLC remains unclear, the association of AXL upregulation with the acquisition of the EGFR C797S mutation raised the possibility of targeting AXL for the treatment of NSCLC harboring this mutation.